S.Korea approves Moderna's COVID-19 vaccine
- 4 years ago
South Korea on Friday approved Moderna Inc's (MRNA.O) COVID-19 vaccine, as the country attempts to speed up its inoculation efforts, drug safety minister Kim Gang-lip told a news conference.
The green light comes after two of three expert panels recommended approval be granted for the two-dose vaccine based on safety and efficacy in late-stage trials in the United States. read more
Moderna is the fourth COVID-19 vaccine to be approved in South Korea, following doses developed by AstraZeneca Plc (AZN.L), Pfizer Inc (PFE.N) and Johnson & Johnson (JNJ.N), said Kim.
Moderna has a deal with South Korea to supply 40 million doses of its vaccine, although the shipment timeline is yet to be announced.
South Korean drugmaker GC Pharma (006280.KS) is in charge of the import and local distribution of the Moderna vaccine, while there were media reports about a plan by Samsung BioLogics Co Ltd (207940.KS) to produce the shots locally.
Source: Reuters
Comments